INMB Next Earnings Date Notes

— INmune Bio (INMB) is a clinical-stage biotechnology company focused on developing therapies that target innate immune system dysfunction to treat serious diseases such as neurodegenerative disorders (notably Alzheimer’s) & cancer. The company’s two lead platforms are XProTM, an inhibitor designed to reduce neuroinflammation, & INB03TM, which targets tumor resistance mechanisms in cancer. Both are in clinical trials, with recent emphasis on XPro’s potential disease-modifying role in Alzheimer’s disease. As an investor listening to earnings calls, key business metrics to track include clinical trial progress (especially positive safety & efficacy data), enrollment updates, regulatory milestones (IND filings, Fast Track status, etc.), cash position & burn rate (vital for non-revenue biotech firms), and management commentary on partnership or licensing activity. Because INmune Bio does not yet generate product revenue, investor focus should be on pipeline advancement, runway for future operations, and any signals regarding upcoming catalysts or competitive differentiators. Jot down updates on clinical timelines & expected data releases, as these are often the primary drivers of valuation in developmental biotech companies like INMB. The next projected earnings date for INMB is 10/29/2026 after close (stay tuned for a confirmed earnings date once announced).

INMB Next Earnings Date FAQ

On this page we presented the INMB Next Earnings Date information for INmune Bio along with recent past earnings dates. For Q2 of 2026, INMB reported earnings of -0.050/share, with the earnings report taking place on 8/6/2026. For Q1 of 2026, INMB reported earnings of -0.200/share, with the earnings report taking place on 5/7/2026. For Q4 of 2025, INMB reported earnings of -0.180/share, with the earnings report taking place on 3/30/2026. For Q3 of 2025, INMB reported earnings of -0.240/share, with the earnings report taking place on 10/30/2025. For Q2 of 2025, INMB reported earnings of -0.340/share, with the earnings report taking place on 8/7/2025. Based on these past earnings dates, the projected next earnings date for INMB is 10/29/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as INmune Bio. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to INmune Bio shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research INmune Bio next earnings dates as well as any other stock out there in our coverage universe, to see when the next INMB earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up INMB's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the INMB next earnings date.